Journal
JOURNAL OF SCLERODERMA AND RELATED DISORDERS
Volume 5, Issue 3, Pages 178-191Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/2397198320902667
Keywords
Inflammatory myositis; antisynthetase syndrome; interstitial lung disease; myositis-specific antibodies; clinicoserological spectrum
Categories
Ask authors/readers for more resources
The discovery of novel autoantibodies related to idiopathic inflammatory myopathies (collectively referred to as myositis) has not only advanced our understanding of the clinical, serological, and pathological correlation in the disease spectrum but also played a role in guiding management and prognosis. One group of the myositis-specific autoantibodies is anti-aminoacyl-tRNA synthetase (anti-ARS or anti-synthetase) which defines a syndrome with predominant interstitial lung disease, arthritis, and myositis. Autoantibodies to eight aminoacyl-tRNA synthetases have been identified with anti-Jo1 the most common in all of idiopathic inflammatory myopathies. Disease presentation and prognosis vary depending on which anti-aminoacyl-tRNA synthetase antibody is present. In this review, we will discuss the clinical characteristics, overlap features with other autoimmune diseases, prognostic factors, and management of the antisynthetase syndrome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available